Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Single-chain antibody specifically binding MG7, highly glycosylated CEA and use thereof in detection and therapy

Single-chain antibody specifically binding MG7, highly glycosylated CEA and use thereof in detection and therapy

US Patent 11266688 · Granted Mar 8, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fully enclosed cell culture system2025
Antibody specifically bound to glycosylated CEACAM52024
Gene composition for detecting cell proliferative abnormality or grading disease2023
Gene composition for detecting cell proliferative abnormality or grading disease2023
Gene composition for detecting cell proliferative abnormality or grading disease2023
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof2022
Fully automated continuous cell culture system2021
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof2019
IL-15 heterodimeric protein and uses thereof2019
Human insulin analogue and acylated derivative thereof2016
Uses of the human ZFX gene and drugs associated with same2016
Pyrimidine nucleoside derivatives, synthesis methods and uses thereof for prepar2016